Dr. Zlatko Kopecki obtained his Bachelor of Laboratory Medicine with Honours from the University of South Australia in 2007 and his Ph.D. in Medicine from the University of Adelaide in 2011. He is a past NHMRC Fellow (2012–2015), a Future Industries Institute Foundation Senior Research Fellow (2015–2021), and a current Channel 7 Children’s Research Foundation Fellow in Childhood Wound Infections (2021–2026) at the University of South Australia. Dr. Kopecki’s research integrates biomaterials, nanotechnology, and antibody approaches to develop frontier technologies for improved wound care for children suffering from skin blistering disease Epidermolysis Bullosa (EB) and, more specifically, novel treatments to combat wound infection. He has established a profile as an emerging Research Leader in skin blistering and his leadership skills and international training in this area place him in the right position to direct translational research and deliver real outcomes for children with chronic wounds. His research is focused on understanding the bacterial composition of blister wounds, which will guide the development of targeted approaches to combat infection as well as inform clinical EB management and antibiotic stewardship.
Research Keywords & Expertise
Cancer
Fibrosis
Inflammation
Psoriasis
Wound Healing
wound infection
Epidermolysis Bullosa
Skin blistering
Short Biography
Dr. Zlatko Kopecki obtained his Bachelor of Laboratory Medicine with Honours from the University of South Australia in 2007 and his Ph.D. in Medicine from the University of Adelaide in 2011. He is a past NHMRC Fellow (2012–2015), a Future Industries Institute Foundation Senior Research Fellow (2015–2021), and a current Channel 7 Children’s Research Foundation Fellow in Childhood Wound Infections (2021–2026) at the University of South Australia. Dr. Kopecki’s research integrates biomaterials, nanotechnology, and antibody approaches to develop frontier technologies for improved wound care for children suffering from skin blistering disease Epidermolysis Bullosa (EB) and, more specifically, novel treatments to combat wound infection. He has established a profile as an emerging Research Leader in skin blistering and his leadership skills and international training in this area place him in the right position to direct translational research and deliver real outcomes for children with chronic wounds. His research is focused on understanding the bacterial composition of blister wounds, which will guide the development of targeted approaches to combat infection as well as inform clinical EB management and antibiotic stewardship.
Well done!
